Brad Hively, Director at Oncology Institute, Inc. (TOI), bought 300,000 shares at $0.15 ($50K) on 2024-12-02, disclosed to the SEC on 2024-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.17 | 250,000 | $43K | 85.0% |
| 2 | $0.15 | 50,000 | $8K | 15.0% |
| Total | $0.17 avg | 300,000 | $50K | 100% |
| Filing → |
| TOI | SELL | 2025-08-21 | $164K | — | Filing → |
| TOI | SELL | 2025-06-05 | $11.3M | — | Filing → |
| TOI | BUY | 2025-04-28 | $47K | — | Filing → |